Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2021 08:23 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present at 39th Annual J.P. Morgan Healthcare Conference

AUSTIN, TX and DURHAM, NC, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
December 18, 2020 18:42 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Added to Russell 2000® and 3000® Indexes

AUSTIN, TX and DURHAM, NC, Dec. 18, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
November 25, 2020 16:30 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present Virtually at Evercore ISI 3rd Annual HealthCONx Conference

AUSTIN, TX and DURHAM, NC, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
November 13, 2020 06:00 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Reports Third Quarter 2020 Financial Results and Recent Business Highlights

– Initiated Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), for the treatment of ovarian cancer – – Completed initial public offering in October...
November 11, 2020 09:27 ET | Source: Shattuck Labs, Inc.

Shattuck Labs Announces Preclinical Proof of Concept Study on Gamma Delta T Cell Engager, GADLEN™, Platform at SITC 2020

AUSTIN, TX and DURHAM, NC, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
November 06, 2020 08:00 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present Virtually at Cowen 4th Annual IO Next Summit

AUSTIN, TX and DURHAM, NC, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
November 05, 2020 08:00 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present Poster on Gamma Delta T Cell Engager, GADLEN™, Platform at the Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting

AUSTIN, TX and DURHAM, NC, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion...
October 29, 2020 08:30 ET | Source: Shattuck Labs, Inc.

Shattuck Labs to Present at CD47|Sirpα Summit 2020

DURHAM, N.C. and AUSTIN, Texas, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional...